MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CCEL — Cryo-Cell International Inc.

NYSE American

Cryo-Cell International Inc.

CompareBack to Screener
$3.99
-0.06(-1.48%)
O
4.11
H
4.11
L
3.99
V
1.49K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About CCEL

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

IndustrySERVICES-MISC HEALTH & ALLIED SERVICES, NEC
SectorNot available
IPO DateNot available
Employees76
Stock ExchangeNYSE American
Ticker SymbolCCEL

Key Financial Statistics

Market Cap$34.19M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$2.72 - $4.90
52-Week Avg Volume13.4K
VWAP$4.09
Transactions189
Total Recorded Bars8,179 days